化合物 Zotiraciclib HCl T70897
面议
- TargetMol
- 生产商
- 进口
- 美国
- 现货
- 全国
- 3
- 1
Product IntroductionBioactivity英文名: Zotiraciclib HCl描述: Zotiraciclib, also known as TG02 and SB1317, is a novel small mol
AI问答
配套的仪器设备？
可以搭配的相关耗材试剂？
耗材描述
Product Introduction
Bioactivity
英文名: Zotiraciclib HCl
描述: Zotiraciclib, also known as TG02 and SB1317, is a novel small molecule potent CDK/JAK2/FLT3 inhibitor. Zotiraciclib may be useful for the treatment of cancer that crosses the blood brain barrier and acts by depleting Myc through the inhibition of cyclin-dependent kinase 9 (CDK9). It is one of a number of CDK inhibitors under investigation; others targeting CDK9 for the treatment of acute myeloid leukemia include alvocidib and atuveciclib. Myc overexpression is a known factor in many cancers, with 80 percent of glioblastomas characterized by this property.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
关键字: 4SC-101 | IMU838 | SC-12267 | IMU-838 | Zotiraciclib HCl | IM-90838 | Vidofludimus | IM90838 | IMU 838 | 4SC101 | SC12267 | SC 12267 | 4SC 101 | IM 90838
Bioactivity
英文名: Zotiraciclib HCl
描述: Zotiraciclib, also known as TG02 and SB1317, is a novel small molecule potent CDK/JAK2/FLT3 inhibitor. Zotiraciclib may be useful for the treatment of cancer that crosses the blood brain barrier and acts by depleting Myc through the inhibition of cyclin-dependent kinase 9 (CDK9). It is one of a number of CDK inhibitors under investigation; others targeting CDK9 for the treatment of acute myeloid leukemia include alvocidib and atuveciclib. Myc overexpression is a known factor in many cancers, with 80 percent of glioblastomas characterized by this property.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
关键字: 4SC-101 | IMU838 | SC-12267 | IMU-838 | Zotiraciclib HCl | IM-90838 | Vidofludimus | IM90838 | IMU 838 | 4SC101 | SC12267 | SC 12267 | 4SC 101 | IM 90838
猜你喜欢
感兴趣产品